Gerald Phd McMahon's Net Worth
$26.7 Million
Who is Gerald Phd McMahon?
Gerald Phd McMahon has an estimated net worth of $26.7 Million. This is based on reported shares across multiple companies, which include Celldex Therapeutics, Inc., NEORX CORP, Harpoon Therapeutics, Inc., and OXIGENE INC.
SEC CIK
Gerald Phd McMahon's CIK is 0001290747
Past Insider Trading and Trends
2008 was Gerald Phd McMahon's most active year for acquiring shares with 8 total transactions. Gerald Phd McMahon's most active month to acquire stocks was the month of May. 2018 was Gerald Phd McMahon's most active year for disposing of shares, totalling 12 transactions. Gerald Phd McMahon's most active month to dispose stocks was the month of May. 2006 saw Gerald Phd McMahon paying a total of $4,177,500.00 for 3,750,000 shares, this is the most they've acquired in one year. In 2017 Gerald Phd McMahon cashed out on 60,120 shares for a total of $192,809.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Celldex Therapeutics, Inc. (CLDX) Snapshot price: $44
InvestorGerald Phd McMahon owns 232,953 units of Common Stock, par value $.001 per share which is worth $10,249,932.00, 192,110 units of Common Stock, par value $0.001 per share which is worth $8,452,840.00 and 180,697 units of Common Stock, par value $0.001 which is worth $7,950,668.00. In the year 2016 Gerald Phd McMahon filed a total of 26 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.54% | -2.82K |
$0.30 | -$843.25 | 180.7K |
Dec 3
| |||
Form 4
| -1.55% | -2.89K |
$0.31 | -$908.28 | 183.52K |
Nov 1
| |||
Form 4
| -1.53% | -2.89K |
$0.45 | -$1,302.49 | 186.41K |
Oct 1
| |||
Form 4
| -1.46% | -2.81K |
$0.50 | -$1,412.13 | 189.3K |
Sep 4
| |||
Form 4
| -1.44% | -2.81K |
$0.47 | -$1,308.04 | 192.11K |
Aug 1
| |||
Form 4
| -1.42% | -2.81K |
$0.50 | -$1,416.63 | 194.92K |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| -1.40% | -2.81K |
$0.58 | -$1,632.10 | 197.74K |
Jun 1
| |||
Form 4
| -1.38% | -2.81K |
$0.74 | -$2,081.62 | 200.55K |
May 1
| |||
Form 4
| -1.63% | -3.38K |
$2.33 | -$7,873.07 | 203.36K |
Apr 2
| |||
Form 4
| -1.62% | -3.42K |
$2.25 | -$7,683.75 | 206.74K |
Mar 1
| |||
Form 4
| -1.60% | -3.42K |
$2.76 | -$9,425.40 | 210.16K |
Feb 1
| |||
Form 4
| -1.69% | -3.67K |
$2.84 | -$10,408.60 | 213.57K |
Jan 2
| |||
Form 4
| -1.46% | -3.21K |
$3.00 | -$9,636.00 | 217.24K |
Dec 1
| |||
Form 4
| -1.44% | -3.21K |
$2.44 | -$7,837.28 | 220.45K |
Nov 1
| |||
Form 4
| -1.42% | -3.21K |
$2.86 | -$9,186.32 | 223.66K |
Oct 2
| |||
Form 4
| -1.40% | -3.21K |
$2.46 | -$7,901.52 | 226.87K |
Sep 1
| |||
Form 4
| -1.23% | -2.87K |
$2.29 | -$6,570.01 | 230.08K |
Aug 1
| |||
Form 4
| -1.22% | -2.87K |
$2.47 | -$7,086.43 | 232.95K |
Jul 3
| |||
Form 4
| +4.43% | 10K |
—
|
—
| 235.82K |
Jun 15
| |||
Form 4
| -1.25% | -2.87K |
$2.83 | -$8,119.27 | 225.82K |
Jun 1
| |||
Form 4
| -1.24% | -2.87K |
$3.33 | -$9,553.77 | 228.69K |
May 1
| |||
Form 4
| -1.22% | -2.87K |
$3.61 | -$10,357.09 | 231.56K |
Apr 3
| |||
Form 4
| -12.32% | -32.93K |
$3.54 | -$116,561.58 | 234.43K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NEORX CORP No price found
Chief Executive OfficerGerald Phd McMahon owns 5,000 units of NeoRx Corporation Common Stock, 19,608 units of Common Stock and 73,826 units of Common Stock (PARD). In the year 2004 Gerald Phd McMahon filed a total of 17 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +276.51% | 54.22K |
—
|
—
| 73.83K |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +61.94% | 7.5K |
$1.29 | $9,707.00 | 19.61K |
Dec 30
| |||
Form 4
| +155.82% | 7.38K |
$1.40 | $10,325.00 | 12.11K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
| +468.19% | 3.9K |
$3.93 | $15,327.00 | 4.73K |
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
∞
| 5K |
$2.75 | $13,750.00 | 5K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Harpoon Therapeutics, Inc. (HARP) No price found
President and CEOGerald Phd McMahon owns 172,462 units of Common Stock. In the year 2019 Gerald Phd McMahon filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +5,648.73% | 169.46K |
$0.60 | $101,677.20 | 172.46K |
Jun 5
| |||
Form 4
| +50.00% | 1K |
$10.16 | $10,157.30 | 3K |
May 14
| |||
Form 4
| +100.00% | 1K |
$10.56 | $10,558.70 | 2K |
May 8
| |||
Form 4
|
∞
| 1K |
$10.53 | $10,530.00 | 1K |
May 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
OXIGENE INC (OTLC) Snapshot price: $0.02296
InvestorGerald Phd McMahon owns 18,611 units of Common Stock, $0.01 par value per share which is worth $427.31. In the year 2011 Gerald Phd McMahon filed a total of 11 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
| +26.06% | 3.85K |
—
|
—
| 18.61K |
Jul 2
| |||
Form 4
| +32.06% | 3.58K |
—
|
—
| 14.76K |
Jan 2
| |||
Form 4
| +196.32% | 7.41K |
—
|
—
| 11.18K |
Jul 1
| |||
Form 4
|
∞
| 3.77K |
—
|
—
| 3.77K |
Jan 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |